|
|
The role of CDK1 siRNA interference in cell cycle
and cell apoptosis |
Hui XIAO PhD,Ming TIAN MM,Junna GE MM,Xin Wei MD,Zhaoming LI MM,Xiaolan LI MS,Deding TAO PhD,Junbo HU MD,Jianping GONG MD, |
Cancer Research Institute,
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology, Wuhan 430030, China; |
|
|
Abstract In the present report, cyclin-dependent kinase1 (CDK1) siRNA was transfected into cells to silence the CDK1 gene expression and study its role in the cell cycle and cell apoptosis. The siRNA targeting CDK1 gene was chemically synthesized and transfected into Hela cells by lipofectamine 2000. The expression levels of CDK1 gene and protein were examined by real-time quantitative polymerase chain reaction (PCR) and Western blot, respectively. The cell cycle was analyzed by using DNA content analysis by flow cytometry. Cell apoptosis was detected by the Annexin V/PI method. The morphological changes of transfected cells were examined under the microscopy by Wright-Giemsa stain. CDK1 gene was successfully silenced by its siRNA, and the CDK1 protein expression level was decreased significantly, especially from 48thh to 60thh after transfection. The DNA content analysis showed that transfection of CDK1 siRNA led to cells accumulating in G2/M phase. There was no significant difference in the apoptotic rate between transfected cells and the control cells after transfection of CDK1 siRNA for 48 or 60h. More double nucleus or multinucleus cells could be seen under the microscopy among the transfected cells. The decreased CDK1 expression by siRNA silencing gave rise to cell cycle arrest in G2/M phase but did not induce apoptosis.
|
Keywords
cyclin-dependent kinase1
siRNA interference
cell cycle
apoptosis
|
Issue Date: 05 December 2009
|
|
|
Evan G I, Vousden K H. Proliferation, cell cycleand apoptosis in cancer. Nature, 2001, 411(6835): 342―349
doi: 10.1038/35077213
|
|
Blagosklonny M V. Apoptosis, proliferation, differentiation: in search of the order. Semin Cancer Biol, 2003, 13(2): 97―105
doi: 10.1016/S1044-579X(02)00127-X
|
|
Park M T, Lee S J. Cell cycle and cancer. J Biochem Mol Biol, 2003, 36(1): 60―65
|
|
Karin M, Lin A. NF-κB at the crossroadsof life and death. Nat Immunol, 2002, 3(3): 221―227
doi: 10.1038/ni0302-221
|
|
Vermeulen K, Berneman Z N, Van Bockstaele D R. Cell cycle and apoptosis. Cell Prolif, 2003, 36(3): 165―175
doi: 10.1046/j.1365-2184.2003.00267.x
|
|
Maddika S, Ande S R, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda K D, Wiechec E, Los M. Cell survival,cell death and cell cycle pathways are interconnected: implicationsfor cancer therapy. Drug Resist Updat, 2007, 10(1,2): 13―29
|
|
Morgam D O. Principles of CDK regulation. Nature, 1995, 374(6518): 131―134
doi: 10.1038/374131a0
|
|
Nurse P. Universalcontrol mechanism regulating onset of M phase. Nature, 1990, 344(6266): 503―508
doi: 10.1038/344503a0
|
|
Hunter T. Brakingthe cycle. Cell, 1993, 75(5): 839―841
doi: 10.1016/0092-8674(93)90528-X
|
|
Harlow E, Lane D. Antibodies: A LaboratoryManual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1988, 450
|
|
Valcourt U, Gouttenoire J, Moustakas A, Herbage D, Mallein-Gerin F. Functions of transforminggrowth factor-beta family type I receptors and Smad proteins in thehypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem, 2002, 277(37): 33545―33558
doi: 10.1074/jbc.M202086200
|
|
Kirou K A, Lee C, George S, Louca K, Papagiannis I G, Peterson M G, Ly N, Woodward R N, Fry K E, Lau A Y, Prentice J G, Wohlgemuth J G, Crow M K. Coordinateoverexpression of interferon-alpha-induce- genes in systemic lupuserythematosus. Arthritis Rheum, 2004, 50(12): 3958―3967
doi: 10.1002/art.20798
|
|
Kirou K A, Lee C, Crow M K. Measurement of cytokines in autoimmune disease. Methods Mol Med, 2004, 102: 129―154
|
|
Koopman G, Reutelingsperger C P, Kuijten G A, Keehnen R M, Pals S T, van Oers M H. Annexin V for flow cytometricdetection of phosphatidylserine expression of B cells undergoing apoptosis. Blood, 1994, 84(5): 1415―1420
|
|
Fadok V A, Voelker D R, Cammpbell P A, Cohen J J, Bratton D L, Henson P M. Exposure of phosphatidylserine on the surface of apoptoticlymphocytes triggers specific recognition and removal by macrophages. J Immunol, 1992, 148(7): 2207―2216
|
|
Bühler M, Moazed D. Transcription and RNAi inheterochromatic gene silencing. Nat StructMol Biol, 2007, 14(11): 1041―1048
doi: 10.1038/nsmb1315
|
|
Scoazec J Y. The RNA revolution. Ann Pathol, 2006, 26(4): 2752―2780
|
|
Tachikawa K, Briggs S P. Targeting the human genome. Curr Opin Biotechnol, 2006, 17(6): 659―665
doi: 10.1016/j.copbio.2006.10.010
|
|
Ying S Y, Chang D C, Miller J D, Lin S L. The microRNA:overview of the RNA gene that modulates gene functions. Methods Mol Biol, 2006, 342: 1―18
|
|
Zender L, Kubicka S. SiRNA based strategies forinhibition of apoptotic pathways in vivo-analytical and therapeuticimplications. Apoptosis, 2004, 9(1): 51―54
doi: 10.1023/B:APPT.0000012121.52210.23
|
|
Roberts J M. Evolving ideas about cyclins. Cell, 1999, 98(2): 129―132
doi: 10.1016/S0092-8674(00)81007-7
|
|
Nasmyth K. Viewpoint:putting the cell cycle in order. Science, 1996, 274(5293): 1643―1645
doi: 10.1126/science.274.5293.1643
|
|
Shi L, Nishioka W K, Th'ng J, Bradbury E M, Litchfield D W, Greenbergl A H. Premature p34cdc2 activation required for apoptosis. Science, 1994, 263(5150): 1143―1145
doi: 10.1126/science.8108732
|
|
Hahntow I N, Schneller F, Oelsner M, Weick K, Ringshausen I, Fend F, Peschel C, Decker T. Cyclin-dependent kinase inhibitorroscovitine induces apoptosis in chronic lymphocytic leukemia cells. Leukemia, 2004, 18(4): 747―755
doi: 10.1038/sj.leu.2403295
|
|
Golsteyn R M. Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis:a role beyond the cell cycle. Cancer Lett, 2005, 217(2): 129―138
doi: 10.1016/j.canlet.2004.08.005
|
|
Rideout H J, Wang Q, Park D S, Stefanis L. Cyclin-dependentkinase activity is required for apoptotic death but not inclusionformation in cortical neurons after proteasomal inhibition. J Neurosci, 2003, 23(4): 1237―1245
|
|
Gartel A L. The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res, 2005, 29(11): 1237―1238
doi: 10.1016/j.leukres.2005.04.023
|
|
Davido D J, Leib D A, Schaffer P A. The cyclin-dependent kinase inhibitor roscovitine inhibitsthe transactivating activity and alters the posttranslational modificationof herpes simplex virus type 1 ICP0. JVirol, 2002, 76(3): 1077―1088
|
|
Edamatsu H, Gau C L, Nemoto T, Tamanoi F. Cdkinhibitors, roscovitine and olomoucine, synergize with farnesyltransferaseinhibitor (FTI) to induce efficient apoptosis of human cancer celllines. Oncogene, 2000, 19(27): 3059―3068
doi: 10.1038/sj.onc.1203625
|
|
Alvi A J, Austen B, Weston V J, Fegan C, Maccallum D, Gianella-Borradori A, Lane D P, Hubank M, Powell J E, Wei W, Taylor A M, Moss P A, Stankovic T. A novel CDK inhibitor, CYC202(R-roscovitine), overcomes the defect in p53-dependent apoptosis inB-CLL by down-regulation of genes involved in transcription regulationand survival. Blood, 2005, 105(11): 4484―4491
doi: 10.1182/blood-2004-07-2713
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|